Choreo LLC increased its position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 9.5% during the second quarter, HoldingsChannel reports. The fund owned 28,161 shares of the company’s stock after buying an additional 2,432 shares during the quarter. Choreo LLC’s holdings in Colgate-Palmolive were worth $2,560,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of CL. Westside Investment Management Inc. increased its stake in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after buying an additional 130 shares during the period. Saudi Central Bank bought a new stake in Colgate-Palmolive during the 1st quarter worth approximately $29,000. Ransom Advisory Ltd acquired a new position in Colgate-Palmolive in the 1st quarter valued at approximately $33,000. Y.D. More Investments Ltd bought a new position in shares of Colgate-Palmolive during the first quarter valued at $37,000. Finally, MTM Investment Management LLC acquired a new position in shares of Colgate-Palmolive during the second quarter worth $39,000. 80.41% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
CL has been the subject of a number of recent research reports. Barclays decreased their price objective on Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. The Goldman Sachs Group decreased their price target on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research note on Thursday, October 2nd. Raymond James Financial cut their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. UBS Group reduced their target price on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating on the stock in a report on Monday, November 3rd. Finally, Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a report on Monday, November 3rd. Nine investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $89.87.
Colgate-Palmolive Price Performance
Shares of CL opened at $80.14 on Friday. The firm has a market cap of $64.59 billion, a PE ratio of 22.51, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The business’s 50 day moving average price is $78.57 and its two-hundred day moving average price is $84.54.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.91 EPS. On average, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Stockholders of record on Friday, October 17th were given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend was Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is 58.26%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- 3 Tickers Leading a Meme Stock Revival
- Keysight Technologies’ Surge: The Market Wakes Up to This AI Play
- What is a Death Cross in Stocks?
- Is American Express the Credit Stock For a K-Shaped Economy?
- Differences Between Momentum Investing and Long Term Investing
- Powering Up: How a Credit Upgrade Fuels Vistra’s AI Ambitions
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
